Literature DB >> 8422241

Interleukin 1 receptor on fibroblasts from systemic sclerosis patients induces excessive functional responses to interleukin 1 beta.

Y Kawaguchi1, M Harigai, K Suzuki, M Hara, K Kobayashi, T Ishizuka, Y Matsuki, N Tanaka, H Nakamura.   

Abstract

To determine if SSc fibroblasts are more sensitive to exogenous IL-1 than are normal fibroblasts, we studied the inductions of IL-6, prostaglandin E2 (PGE2), IL-1 beta mRNA production by IL-1-stimulated SSc and normal fibroblasts. The minimal IL-1 beta concentrations for stimulation of IL-6 and PGE2 production by SSc fibroblasts were 10-fold and 100-fold lower, respectively, than those for normal fibroblasts. The minimal IL-1 beta concentration for stimulation of IL-1 beta mRNA expression by SSc fibroblasts was also 10-fold lower than that for normal fibroblasts. These results suggest that the IL-1 signal transduction through IL-1R could be induced excessively in SSc fibroblasts. It is suggested that the IL-1 signal transduction plays an important role in the abnormal cytokine networks observed in the fibrosis of SSc.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8422241     DOI: 10.1006/bbrc.1993.1024

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Endogenous IL-1alpha from systemic sclerosis fibroblasts induces IL-6 and PDGF-A.

Authors:  Y Kawaguchi; M Hara; T M Wright
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

Review 2.  Cytokines in the immunopathology of systemic sclerosis.

Authors:  Jasmin Raja; Christopher Paul Denton
Journal:  Semin Immunopathol       Date:  2015-07-08       Impact factor: 9.623

3.  Association of interleukin 1 family with systemic sclerosis.

Authors:  Li Zhang; Jun-Wei Yan; Yu-Jie Wang; Ya-Nan Wan; Bing-Xiang Wang; Jin-Hui Tao; Bing Chen; Bao-Zhu Li; Guo-Jun Yang; Jing Wang
Journal:  Inflammation       Date:  2014-08       Impact factor: 4.092

4.  Elevated serum levels of interleukin-1β and interleukin-33 in patients with systemic sclerosis in Chinese population.

Authors:  Y-J Zhang; Q Zhang; G-J Yang; J-H Tao; G-C Wu; X-L Huang; Y Duan; X-P Li; D-Q Ye; J Wang
Journal:  Z Rheumatol       Date:  2018-03       Impact factor: 1.372

5.  IL-1 alpha gene expression and protein production by fibroblasts from patients with systemic sclerosis.

Authors:  Y Kawaguchi
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

6.  Increased endothelin-1 production in fibroblasts derived from patients with systemic sclerosis.

Authors:  Y Kawaguchi; K Suzuki; M Hara; T Hidaka; T Ishizuka; M Kawagoe; H Nakamura
Journal:  Ann Rheum Dis       Date:  1994-08       Impact factor: 19.103

Review 7.  An Update on PYRIN Domain-Containing Pattern Recognition Receptors: From Immunity to Pathology.

Authors:  Rojo A Ratsimandresy; Andrea Dorfleutner; Christian Stehlik
Journal:  Front Immunol       Date:  2013-12-09       Impact factor: 7.561

Review 8.  Natural Formulations: Novel Viewpoint for Scleroderma Adjunct Treatment.

Authors:  Shirin Assar; Hosna Khazaei; Maryam Naseri; Fardous El-Senduny; Saeideh Momtaz; Mohammad Hosein Farzaei; Javier Echeverría
Journal:  J Immunol Res       Date:  2021-06-24       Impact factor: 4.818

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.